
Actipulse Neuroscience
Actipulse Neuroscience is a YC Winter 2022 (W22) company. Based in Cambridge, MA, USA; Mexico City, CDMX, Mexico. Team of 38.
About Actipulse Neuroscience
Summary
Actipulse Neuroscience builds a proprietary non-invasive brain stimulation device that lets patients with Major Depressive Disorder receive treatment at home rather than in a hospital. The device uses high-frequency magnetic pulses to deliver transcranial neuromodulation, replacing clinic-based sessions that are expensive and logistically burdensome. The company is advancing the same technology into pilot studies for Alzheimer's and Parkinson's disease.
From the Y Combinator listing
Bringing non-invasive brain stimulation from the hospital to the home
Non-invasive brain stimulation is a widely-utilized, FDA cleared treatment used for patients diagnosed with depression, but is limited to a hospital setting due to the cost of the device, and complexity of treatment application. Our proprietary brain stimulation device allows patients to be treated directly from their home, with the same efficacy, and at a lower cost of treatment. Currently in FDA pivotal phase for Major Depressive Disorder, and Pilot phase for Alzheimer's and Parkinson diseases.
Facts
- Healthcare / Healthcare -> Medical Devices
- Cambridge, MA, USA; Mexico City, CDMX, Mexico
- 38
- Active
- Early
Founders (2)
- Adrien Châtillon
Score every batch against your own thesis
GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.
How Accelerator intelligence works